Endothelial Growth Factor Receptor

Known as: Receptor, Endothelial Growth Factors 
 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (2)

Vascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-1

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling.
YAP signaling pathway plays critical roles in tissue homeostasis, and aberrant activation of YAP signaling has been implicated in… (More)
Is this relevant?
2014
2014
Clinicopathologic features of breast carcinomas classified by biomarkers and correlation with microvessel density and VEGF expression: a study from Thailand.
BACKGROUND To correlate breast cancer subtypes with prognostic factors, microvessel density (MVD), vascular endothelial growth… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2014
2014
Genentech to salvage anti-MET antibody with subgroup analysis
“The decision to pursue the phase 3 METLung study was based on the positive results of the phase 2 NSCLC study seen in a… (More)
  • table 1
Is this relevant?
2013
2013
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.
BACKGROUND Patients with colorectal cancer (CRC) with wild-type KRAS mutations are often treated with the endothelial growth… (More)
Is this relevant?
2013
2013
Targeted therapy-induced radiation recall.
INTRODUCTION Radiation recall (RR) is an acute inflammatory reaction confined to previously irradiated areas after the… (More)
Is this relevant?
2011
2011
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer.
PURPOSE Phase II trials in locally advanced rectal cancer have shown that cetuximab-based neoadjuvant radiochemotherapy is… (More)
Is this relevant?
2010
2010
RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab
BACKGROUND Local control in adjuvant/definitive RT of adenoid cystic carcinoma (ACC) is largely dose-dependent. However, some… (More)
  • figure 1
  • table 1
  • table 4
  • table 2
  • table 3
Is this relevant?
2009
2009
Predictive biomarkers: identification and verification.
The holy grail of cancer therapy in the near future could relate to the identification of biomarkers that might enable… (More)
Is this relevant?
2008
2008
Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation…
Lysophosphatidic acid (LPA) is a lipid bioactive mediator which binds to G-protein-coupled receptors and activates a variety of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
Gene therapy for meningioma: improved gene delivery with targeted adenoviruses.
OBJECT Due to their surgical inaccessibility or aggressive behavior, some meningiomas cannot be cured with current treatment… (More)
Is this relevant?